Clinical Long-Term Response to Cardiac Resynchronization Therapy Is Independent of Persisting Echocardiographic

Barbara Naegeli1, Hans-Peter Brunner-La Rocca2, Christine Attenhofer Jost1

  • 1HerzGefassZentrum, Klinik Im Park, Seestrasse 247, CH-8027 Zurich, Switzerland.

Cardiology Research
|March 30, 2017
PubMed

Insights

Correction of cardiac dyssynchrony after cardiac resynchronization therapy (CRT) is not required for favorable long-term outcomes. Even with persistent dyssynchrony, patients showed similar clinical responses, suggesting CRT effectiveness is independent of echocardiographic parameter correction.

Area of Science:

  • Cardiology
  • Medical Technology

Background:

  • Cardiac resynchronization therapy (CRT) aims to improve outcomes by correcting cardiac dyssynchrony.
  • It was hypothesized that correcting dyssynchrony is crucial for long-term patient response to CRT.

Purpose of the Study:

  • To determine if the correction of dyssynchrony parameters after CRT implantation is a prerequisite for favorable long-term outcomes.
  • To evaluate if persistent dyssynchrony predicts a less favorable response to CRT.

Main Methods:

  • A cohort of 128 patients undergoing CRT implantation were followed for 27 months post-optimization.
  • Long-term outcomes were assessed by a composite of cardiac mortality/heart transplantation and heart failure hospitalizations, with NYHA class as a secondary endpoint.
  • Echocardiographic parameters were used to assess atrioventricular, interventricular, and intraventricular dyssynchrony post-CRT.

Main Results:

  • A clinical response to CRT was observed in 76% of patients, with significant improvement in NYHA class (P < 0.001).
  • Despite optimization, residual dyssynchrony was present in a notable percentage of patients (AV: 7.2%, VV: 13.3%, IV: 16.4%).
  • Crucially, persistent dyssynchrony did not significantly impact the combined primary and secondary endpoints compared to patients without mechanical dyssynchrony.

Conclusions:

  • Successful CRT implantation leads to favorable long-term clinical outcomes irrespective of the complete correction of echocardiographic dyssynchrony parameters.
  • QRS width during biventricular stimulation did not differentiate between responders and non-responders.
  • These findings suggest that CRT efficacy may not solely depend on achieving specific echocardiographic targets for dyssynchrony correction.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
685
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
556
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
734
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
351
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
586
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
688